Authors/Disclosures
Amy R. Borenstein, PhD, FAAN
|
No disclosure on file |
James A. Mortimer, PhD, FAAN
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Tamer Abdelhak, MD
(Albany Medical College)
|
No disclosure on file |
|
No disclosure on file |
David P. Salmon, PhD
(Univ of Calif-San Diego)
|
Dr. Salmon has nothing to disclose. |
|
No disclosure on file |
John M. Olichney, MD
(Center for Mind and Brain)
|
No disclosure on file |
Leon J. Thal, MD
(Dept of Neurosciences UCSD)
|
No disclosure on file |
Lisa Silbert, MD, FAAN
(OHSU)
|
The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
Jeffrey A. Kaye, MD, FAAN
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
|
No disclosure on file |
Gerard Schellenberg, PhD
|
No disclosure on file |
Douglas Galasko, MD
(Dept. of Neurosciences, UCSD)
|
Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for vTv Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMed Central. |